Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Romain Paoli-LombardoService Central de la Qualité et de l'Information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 174 Boulevard Baille, 13005 Marseille, France.
Nicolas PrimasService Central de la Qualité et de l'Information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 174 Boulevard Baille, 13005 Marseille, France.ORCID 0000-0002-6713-6039
Clémence TabéléHealth Services and Quality of Life Research, School of Medicine, Aix-Marseille University, 27 Boulevard Jean Moulin, 13385 Marseille, France.ORCID 0000-0003-1420-0647
Ikram ZaddamService Central de la Qualité et de l'Information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 174 Boulevard Baille, 13005 Marseille, France.
Eya Iben SlimeneService Central de la Qualité et de l'Information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 174 Boulevard Baille, 13005 Marseille, France.
Pascal RathelotService Central de la Qualité et de l'Information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 174 Boulevard Baille, 13005 Marseille, France.ORCID 0000-0002-2132-5862
Patrice VanelleService Central de la Qualité et de l'Information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 174 Boulevard Baille, 13005 Marseille, France.
Caroline Castera-DucrosService Central de la Qualité et de l'Information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 174 Boulevard Baille, 13005 Marseille, France.
Christophe CurtiService Central de la Qualité et de l'Information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 174 Boulevard Baille, 13005 Marseille, France.ORCID 0000-0002-5919-4394
Funding
Aix-Marseille Université (AMU)Hôpitaux Universitaire de Marseille (AP-HM)
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
dose administereddrug compoundinghard gelatin capsulesHPLC-UVpediatric practice
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Hard Gelatin Capsules Compounded and Dispersed in Water in Pediatrics: Real Versus Theoretical Dose Administered. · full record | OpenQuestion